Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
The Biochemical Journal|June 5, 2003
Requirements for distinct steps of phospholipase Cgamma2 regulation, membrane-raft-dependent targeting and subsequent enzyme activation in B-cell signallingRosie Rodriguez, Miho Matsuda, Amy Storey, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|May 12, 2025
Phosphoinositide-specific phospholipase C enzymes: Recent advances in a long journeyCalum Macrae, Damjan Lalović, Tom D Bunney, et al.
Trends in Biochemical Sciences|December 3, 2014
Dysfunction of phospholipase Cγ in immune disorders and cancerHans Koss, Tom D Bunney, Sam Behjati, et al.
Advances in Biological Regulation|September 23, 2024
Characterisation of molecular mechanisms for PLCγ2 disease-linked variantsTom D Bunney, Charis Kampyli, Ashley Gregory, et al.
The Biochemical Journal|June 20, 2002
Biochemical identification of a neutral sphingomyelinase 1 (NSM1)-like enzyme as the major NSM activity in the DT40 B-cell line: absence of a role in the apoptotic response to endoplasmic reticulum stressAmanda C Fensome, Michelle Josephs, Matilda Katan, et al.
Eupa Open Proteomics|April 21, 2015
Evaluation of phosphopeptide enrichment strategies for quantitative TMT analysis of complex network dynamics in cancer-associated cell signallingBenedetta Lombardi, Nigel Rendell, Mina Edwards, et al.
Journal of Cell Science|June 10, 2005
PLCgamma1 is essential for early events in integrin signalling required for cell motilityNeil P Jones, Joanna Peak, Sharon Brader, et al.
International Journal of Molecular Sciences|July 3, 2015
Homo-FRET Based Biosensors and Their Application to Multiplexed Imaging of Signalling Events in Live CellsSean C Warren, Anca Margineanu, Matilda Katan, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 24, 2009
In vitro reconstitution of activation of PLCepsilon by Ras and Rho GTPasesNatalia Lamuño Gandarillas, Tom D Bunney, Michelle B Josephs, et al.
International Journal of Molecular Sciences|May 7, 2020
Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 AlterationsNadia Carvalho Lima, Eliza Atkinson, Tom D Bunney, et al.
Pageof 7